JD Cavenagh. Additional dexamethasone improves the response rate among patients with multiple myeloma treated with single agent bortezomib. Haematologica 2006;91(7):869B-869B; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
